Biggest News Aggregation in the World
📰 Allogeneic News

Page 3 - Allogeneic News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Allogeneic. Real-time updates on events, politics, business and more.

Sana Biotechnology Announces Preclinical Data Published in Nature Biotechnology Demonstrating its Hypoimmune-Engineered Cells Escape Immune Detection and Survive While Remaining Fully Functional

Hypoimmune-modified allogeneic iPSCs evade immune response and rejection without immunosuppression in non-human primate model Long-term survival and immune evasion of hypoimmune-modified allogeneic... | May 8, 2023
United Kingdom Doug Williams Company Securities Sana Biotechnology Inc Exchange Commission Nature Biotechnology

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Precision BioSciences, Inc. , a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that, on April 27, 2023,... | May 8, 2023
Compensation Committee Of Precision Board Directors Precision Biosciences Inc Precision Biosciences Compensation Committee Inducement Incentive Award Plan Nasdaq Listing Rule

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Precision BioSciences Announces Late-Breaking Abstract of Preclinical In Vivo Gene Editing Research Selected for Oral Presentation at the American Society of Gene and Cell Therapy 26th Annual Meeting

DURHAM - Precision BioSciences, Inc. , a clinical stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that a late-breaking... | April 19, 2023
Los Angeles Jeff Smith American Society Of Gene Cell Therapy Precision Biosciences Inc Cell Therapy Annual Meeting

Gamida Cell Ltd. Announces Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval

Gamida Cell Ltd. announced that the U.S. Food and Drug Administration has approved Gamida Cells allogeneic cell therapy, Omisirge® , for use in adult and pediatric patients 12 years and... | April 18, 2023
United States Kiryat Gat Gamida Cell Ltd Drug Administration American Society Of Hematology Gamida Cell

MiNK Therapeutics Announces Clinical Data of Allogeneic iNKT Cells (agenT-797) in Solid Tumor Cancers at the AACR Annual Meeting

Allogeneic iNKTs, agenT-797, administered alone or in combination with anti-PD-1 therapy, shows activity in patients with refractory solid tumor cancers.In a patient with metastatic gastric cancer who... | April 18, 2023
United States New York Memorial Sloan Kettering Cancer Center Jennifer Buell Benedito Carneiro Zack Armen

Allogene Therapeutics Presents Interim Phase 1 Data on ALLO-316 in Renal Cell Carcinoma at the American Association of Cancer Research (AACR) Annual Meeting

Data Provide Proof-of-Concept for an Allogeneic Anti-CD70 CAR T Candidate in Patients with Renal Cell Carcinoma Who Received Prior Immune Checkpoint Inhibitor and VEGF-Targeting TherapySingle... | April 17, 2023
United States Allogene Allo Christine Cassiano Zachary Roberts Samera Srour University Of Texas Md Anderson Cancer Center

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science